Matches in SemOpenAlex for { <https://semopenalex.org/work/W2242689528> ?p ?o ?g. }
Showing items 1 to 64 of
64
with 100 items per page.
- W2242689528 endingPage "e20673" @default.
- W2242689528 startingPage "e20673" @default.
- W2242689528 abstract "e20673 Background: As oncologic therapies have shown improved survival, there is a growing attention to other aspects of the cancer experience from the survivors’ perspectives. Gastrointestinal, constitutional, and dermatologic toxicities are frequently experienced and further study of their impact is important to prevent inconsistent antineoplastic drug administration. This study is aimed to evaluate survivors’ perceptions of unexpected toxicities. Methods: CancerCare, a national nonprofit organization, mailed 1,369 surveys to cancer survivors completing their treatment. The survey divided into two sections asked patients to rate their concern about dermatologic, gastrointestinal, and constitutional toxicities prior to and after therapy completion. Toxicities were also rated on a 1 to 10 scale based on their negative impact. Results: 379 survivors responded to the survey, yielding a 28% response. Of those 379, 250 (66%) were diagnosed with breast cancer. The remaining 127 (33%) had ovarian, lung, colorectal, prostate, bladder, kidney, or other malignancy. Prior treatments included: chemotherapy, radiation, surgery, targeted therapies, or any combination of the preceding. The most frequently unanticipated events carrying a negative impact were dermatologic: dry skin and skin irritation. Following were constitutional (insomnia and fatigue) and gastrointestinal toxicities (diarrhea and constipation). Before undergoing treatment, skin irritation was concerning to 40%. After treatment, 80% reported concern and 47% were negatively impacted. Dry skin prior to treatment was concerning to 34%, and 79% were concerned after having undergone therapy. In retrospect, 44% reported that having dry skin caused a negative impact. Gastrointestinal and constitutional toxicities were also examined, and overall, respondents’ level of concern remained largely unchanged pre and post treatment. Conclusions: Dermatologic toxicities are least anticipated by the cancer patients prior to their treatments, when compared to gastrointestinal and constitutional events. Since dermatologic toxicities have a negative impact on survivors’ lives, pre-therapy counseling and effective interventions are crucial, in order to maximize quality of life. [Table: see text]" @default.
- W2242689528 created "2016-06-24" @default.
- W2242689528 creator A5002599922 @default.
- W2242689528 creator A5032857672 @default.
- W2242689528 creator A5055583729 @default.
- W2242689528 creator A5080393776 @default.
- W2242689528 date "2009-05-20" @default.
- W2242689528 modified "2023-10-18" @default.
- W2242689528 title "Unexpected dermatologic toxicities from anticancer therapies: Survivors’ perspectives" @default.
- W2242689528 doi "https://doi.org/10.1200/jco.2009.27.15_suppl.e20673" @default.
- W2242689528 hasPublicationYear "2009" @default.
- W2242689528 type Work @default.
- W2242689528 sameAs 2242689528 @default.
- W2242689528 citedByCount "0" @default.
- W2242689528 crossrefType "journal-article" @default.
- W2242689528 hasAuthorship W2242689528A5002599922 @default.
- W2242689528 hasAuthorship W2242689528A5032857672 @default.
- W2242689528 hasAuthorship W2242689528A5055583729 @default.
- W2242689528 hasAuthorship W2242689528A5080393776 @default.
- W2242689528 hasConcept C121608353 @default.
- W2242689528 hasConcept C126322002 @default.
- W2242689528 hasConcept C141071460 @default.
- W2242689528 hasConcept C143998085 @default.
- W2242689528 hasConcept C16005928 @default.
- W2242689528 hasConcept C2777035695 @default.
- W2242689528 hasConcept C2777789703 @default.
- W2242689528 hasConcept C2779399171 @default.
- W2242689528 hasConcept C526805850 @default.
- W2242689528 hasConcept C530470458 @default.
- W2242689528 hasConcept C542804219 @default.
- W2242689528 hasConcept C71924100 @default.
- W2242689528 hasConceptScore W2242689528C121608353 @default.
- W2242689528 hasConceptScore W2242689528C126322002 @default.
- W2242689528 hasConceptScore W2242689528C141071460 @default.
- W2242689528 hasConceptScore W2242689528C143998085 @default.
- W2242689528 hasConceptScore W2242689528C16005928 @default.
- W2242689528 hasConceptScore W2242689528C2777035695 @default.
- W2242689528 hasConceptScore W2242689528C2777789703 @default.
- W2242689528 hasConceptScore W2242689528C2779399171 @default.
- W2242689528 hasConceptScore W2242689528C526805850 @default.
- W2242689528 hasConceptScore W2242689528C530470458 @default.
- W2242689528 hasConceptScore W2242689528C542804219 @default.
- W2242689528 hasConceptScore W2242689528C71924100 @default.
- W2242689528 hasIssue "15_suppl" @default.
- W2242689528 hasLocation W22426895281 @default.
- W2242689528 hasOpenAccess W2242689528 @default.
- W2242689528 hasPrimaryLocation W22426895281 @default.
- W2242689528 hasRelatedWork W134396366 @default.
- W2242689528 hasRelatedWork W2042287506 @default.
- W2242689528 hasRelatedWork W2297592050 @default.
- W2242689528 hasRelatedWork W2363413836 @default.
- W2242689528 hasRelatedWork W2409591002 @default.
- W2242689528 hasRelatedWork W2412701647 @default.
- W2242689528 hasRelatedWork W2473759769 @default.
- W2242689528 hasRelatedWork W377899687 @default.
- W2242689528 hasRelatedWork W2183938888 @default.
- W2242689528 hasRelatedWork W2185690298 @default.
- W2242689528 hasVolume "27" @default.
- W2242689528 isParatext "false" @default.
- W2242689528 isRetracted "false" @default.
- W2242689528 magId "2242689528" @default.
- W2242689528 workType "article" @default.